The U.S. Manual Resuscitator Market is witnessing significant traction driven by increasing demand for emergency healthcare solutions and advancements in medical technology. With rising awareness of respiratory support devices and growing investments in healthcare infrastructure, the industry share is poised for continued expansion. Recent market research indicates robust growth momentum aligned with evolving clinical needs and regulatory trends.
Market Size and Overview
The U.S. manual resuscitators market is projected to be worth USD 219.1 Mn in 2026, rising to USD 340.2 Mn by 2033. The market is anticipated to exhibiting a compound annual growth rate (CAGR) of 6.5% during the period of 2026 to 2033.
Market Drivers
- Growth in Emergency Medical Services and Respiratory Care Needs: The primary market driver shaping U.S. Manual Resuscitator Market Growth is the surge in emergency medical services due to increasing incidences of Acute Respiratory Distress Syndrome (ARDS) and respiratory illnesses like COVID-19 sequelae in 2025-2026. For instance, government initiatives to upgrade EMS capabilities in 2026 have boosted manual resuscitator adoption by over 12%, according to recent data. This illustrates strong market opportunities linked to rising patient volumes and focus on life-saving interventions, directly impacting overall market trends and revenue.
PEST Analysis
- Political: In 2025, federal healthcare policies emphasized strengthening emergency preparedness, leading to increased funding for manual resuscitator procurement. Regulatory agencies streamlined device approval processes, positively influencing market dynamics.
- Economic: The U.S. healthcare expenditure growth in 2026, reaching nearly $4.4 trillion, underpins increased investments in medical device markets, making it economically feasible for hospitals to upgrade respiratory care equipment, fostering business growth.
- Social: Demographic shifts, including aging populations with higher chronic respiratory conditions, have amplified demand for manual resuscitators. Public awareness campaigns launched in 2025 have improved acceptance of respiratory aid devices, driving industry size expansions.
- Technological: Technological advancements such as ergonomic designs and enhanced material safety in manual resuscitators introduced in 2026 have improved device efficacy and user convenience, further propelling market growth strategies and creating new market segments.
Promotion and Marketing Initiative
- In 2026, a leading U.S. healthcare provider spearheaded a nationwide campaign focused on educating EMTs and paramedics on the latest manual resuscitator technology. This initiative not only increased brand visibility but also resulted in a 15% increase in device adoption across key urban centers. Such targeted promotion underscores the importance of strategic marketing initiatives in expanding market share and driving demand within the U.S. Manual Resuscitator Market.
Key Players
- Ambu A/S
- Medline Industries LP
- Teleflex Incorporated
- Vyaire Medical Inc.
- Smiths Medical (ICU Medical Inc.)
- Hill-Rom Holdings, Inc.
- Nihon Kohden Corporation
- GE Healthcare
- Philips Healthcare
- Cardinal Health, Inc.
- Baxter International Inc.
- Drägerwerk AG & Co. KGaA
Recent strategies include:
- In 2026, Ambu A/S launched a next-gen manual resuscitator model featuring improved ventilation efficiency, resulting in a 10% revenue increase.
- Medline Industries expanded its distribution network across the U.S., boosting market penetration and achieving higher market share in the last fiscal year.
- Teleflex Incorporated entered strategic partnerships with emergency medical training centers to enhance device training programs, improving market company positioning and user adoption rates.
FAQs
Q1: Who are the dominant players in the U.S. Manual Resuscitator Market?
The dominant market players include Ambu A/S, Medline Industries LP, Teleflex Incorporated, Vyaire Medical Inc., and Smiths Medical (ICU Medical Inc.), with these companies focusing heavily on technological innovation and expanding distribution channels.
Q2: What will be the size of the U.S. Manual Resuscitator Market in the coming years?
The market size is projected to reach USD 340.2 million by 2034 from USD 219.1 million in 2027, driven by a CAGR of 6.5% through this forecast period.
Q3: Which end-user sector has the largest growth opportunity?
Emergency medical services and hospital intensive care units represent the largest growth segments, due to increasing demand for respiratory support in critical care scenarios.
Q4: How will market development trends evolve over the next five years?
Market trends point toward enhanced device ergonomics, increasing integration with digital monitoring systems, and expanding adoption of portable manual resuscitators in pre-hospital care.
Q5: What is the nature of the competitive landscape and challenges in the U.S. Manual Resuscitator Market?
The market is moderately fragmented, with key players investing in R&D and marketing to maintain share. Challenges include regulatory hurdles and rising raw material costs impacting production.
Q6: What go-to-market strategies are commonly adopted in the U.S. Manual Resuscitator Market?
Companies employ product innovation, strategic partnerships with healthcare providers, and training initiatives targeting EMS personnel to enhance product adoption and market penetration.
➣ Get more insights on: U.S. Manual Resuscitators Market
➣ Get this Report in Japanese Language: 米国のマニュアル復元者市場
➣ Get this Report in Korean Language: 미국매뉴얼소생술시장
➣ Read more related articles: Spirometer Industry Analysis – Rising Respiratory Disease Rates Fuels Growth
About Author:
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.